EUVIMEDEUVIMED entdecken
Open Access

Long‐Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry

Angela Y Higgins iD, Sarah Zimmerman iD, Yongfei Wang iD, Daniel J Friedman iD, Kamil F Faridi iD, Matthew J Price iD, Vivek Y Reddy iD, David R Holmes iD, Jeptha P Curtis iD, James V Freeman iD

Journal of the American Heart Association · 19.08.2025 · 14 (16)

DOI: 10.1161/jaha.124.039780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Heart Association, erschienen am 19.08.2025. Verfasst von Angela Y Higgins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine Maine Medical Center Portland ME USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Medicare, Stroke. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Percutaneous left atrial appendage occlusion (LAAO) is an alternative to long‐term anticoagulation for preventing ischemic stroke in patients with atrial fibrillation. There are limited long‐term outcomes data for “real‐world” patients undergoing LAAO.

Methods

We performed a retrospective cohort study using the National Cardiovascular Data Registry LAAO registry from January 1, 2016, through December 31, 2019. We linked LAAO data to inpatient Medicare fee‐for‐service claims data using probabilistic matching to establish a cohort of patients 65 years and older undergoing LAAO with a WATCHMAN device. The primary outcomes were any stroke and all‐cause mortality.

Results

A total of 34 975 patients with a mean±SD CHA 2 DS 2 ‐VASc (congestive heart failure, hypertension, age ≥75 years, diabetes, previous stroke or transient ischemic attack, vascular disease, age 65 to 74 years, and sex category) score of 4.7±1.4 were included. The median follow‐up was 2.8 years (interquartile range, 2.2–3.7 years). The cumulative incidence of any stroke was 1.57 per 100 person‐years (95% CI, 1.45–1.70), with a 1‐year and 5‐year any stroke estimate of 1.70% (95% CI, 1.57–1.84%) and 5.70% (95% CI, 5.37–6.05%), respectively. The cumulative incidence of ischemic stroke was 1.36 per 100 person‐years (95% CI, 1.25–1.48), with a 1‐year and 5‐year ischemic stroke estimate of 1.42% (95% CI, 1.30–1.54%) and 5.03% (95% CI, 4.71–5.36%), respectively. The cumulative incidence of death was 10.82 per 100 person‐years (95% CI, 10.49–11.13), with a 5‐year mortality estimate of 44.34% (95% CI, 43.35–45.23%).

Conclusions

Long‐term stroke rates in a large nationally representative cohort of Medicare patients following LAAO were low and durably consistent during long‐term follow‐up despite a high thromboembolic risk. High mortality rates in this elderly population underscore the importance of incorporating patient values and preferences when considering LAAO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAtrial AppendageMedicareStrokeIschemic StrokeHumansUnited StatesMaleFemaleAgedRegistriesRetrospective StudiesTime FactorsAged, 80 and overTreatment OutcomeIncidenceRisk Factors

Stichwörter der Autor:innen

left atrial appendage occlusionmortalityoutcomesstroke

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine Maine Medical Center Portland ME USA.
  • Section of Cardiovascular Medicine, Department of Internal Medicine Yale University School of Medicine New Haven CT USA.
  • Center for Outcomes Research and Evaluation Yale New Haven Health Services Corporation New Haven CT USA.
  • Division of Cardiology Duke University Medical Center and Duke Clinical Research Institute Durham NC USA.
  • Division of Cardiovascular Diseases Scripps Clinic La Jolla CA USA.
  • Icahn School of Medicine Mount Sinai New York New York USA.

ORCID-Profile: Angela Y Higgins, Sarah Zimmerman, Yongfei Wang, Daniel J Friedman, Kamil F Faridi, Matthew J Price, Vivek Y Reddy, David R Holmes, Jeptha P Curtis, James V Freeman

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Higgins, A. Y., Zimmerman, S., Wang, Y., Friedman, D. J., Faridi, K. F., Price, M. J., Reddy, V. Y., Holmes, D. R., Curtis, J. P., & Freeman, J. V. (2025). Long‐Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry. Journal of the American Heart Association, 14(16). https://doi.org/10.1161/jaha.124.039780

Vancouver

Higgins AY, Zimmerman S, Wang Y, Friedman DJ, Faridi KF, Price MJ, et al. Long‐Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry. Journal of the American Heart Association. 2025;14(16). doi:10.1161/jaha.124.039780

BibTeX
@article{Higgins2025,
  author = {Higgins, Angela Y and Zimmerman, Sarah and Wang, Yongfei and Friedman, Daniel J and Faridi, Kamil F and Price, Matthew J and Reddy, Vivek Y and Holmes, David R and Curtis, Jeptha P and Freeman, James V},
  title = {Long‐Term Outcomes Following Left Atrial Appendage Occlusion in Medicare Beneficiaries: Outcomes From the National Cardiovascular Data Registry},
  journal = {Journal of the American Heart Association},
  year = {2025},
  volume = {14},
  number = {16},
  doi = {10.1161/jaha.124.039780}
}
Kostenlos starten →